FLAEM Hospi Neb JUNIOR F2000 Manual De Instrucciones página 12

Ocultar thumbs Ver también para Hospi Neb JUNIOR F2000:
Tabla de contenido

Publicidad

Idiomas disponibles
  • ES

Idiomas disponibles

  • ESPAÑOL, página 38
7. When the treatment is finished, turn off and unplug the unit.
WARNING: It may happen that after a treatment session visible humidity deposits form in
the tube (B): disconnect the tube from the nebuliser and let it dry using the compressor
air flow, as this prevents mould from growing in the tube.
HOW TO USE RF6 PLUS NEBULISER WITH DOUBLE ACTION VALVE
It is professional, quick and suitable for administering all types of drugs, including more
costly ones, also in patients with chronic diseases. The configuration of the internal lines
of the RF6 Plus nebuliser ensures the ideal granulometry providing effective treatment
right down to the lower airways.
USE WITH MOUTHPIECE
Use the double action valve (C1.4) in position 1. In
this case the inhalation therapy allows the maximum
drug intake and therefore the maximum therapeutic
effect, minimising the loss of medication.
USE WITH MASK AND NASAL PRONG
To make inhalation therapy faster we recommend
using the double action valve (C1.4) in position 2.
To administer the medication only through the nose,
use the non-invasive nasal prong (C3).
NON-SPILL SYSTEM
The RF6 Plus nebuliser is also especially suitable for
pediatric use, since the non-spill system prevents
medication from spilling out even if the nebuliser is
accidentally tipped over.
SOFTTOUCH FACE MASKS
Soft
biocompatible
material
Dispersion
Limiting Vent
During the inspiratory phase,
the tab, acting as a Dispersion
Limiting Device, bends inwards
towards the mask.
SoftTouch masks have an outer edge made of soft bio-
compatible material that ensures excellent adherence
to the face, and is also equipped with an innovative
Dispersion Limiting Device. These distinctive ele-
ments that distinguish it allow greater sedimentation
of medication in the patient and also limit dispersion.
10
VALVE IN
POSITION 1
Efficacy tested up to 5 ml, the average
dose recommended for normal use
During the expiratory phase, the
tab, acting as a Dispersion Lim-
iting Device, bends outwards
from the mask.
VALVE IN
POSITION 2

Publicidad

Tabla de contenido
loading

Tabla de contenido